Structure-activity relationships of 2-(benzothiazolylthio)acetamide class of CCR3 selective antagonist

Chemical and Pharmaceutical Bulletin

Volumn 51, Issue 6, 2003, Pages 697-701

  Naya, Akira ^a   Kobayashi, Kensuke ^a   Ishikawa, Makoto ^a   Ohwaki, Kenji ^a   Saeki, Toshihiko ^a   Noguchi, Kazuhito ^a   Ohtake, Norikazu ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

2 (benzothiazolylthio)acetamide; CCR3; Chemokine

Indexed keywords

ACETAMIDE DERIVATIVE; N [1 (3,4 DICHLOROBENZYL)PIPERIDIN 4 YL] (6 ACETAMIDO 2 BENZOTHIAZOLYLTHIO)ACETAMIDE; N [1 (3,4 DICHLOROBENZYL)PIPERIDIN 4 YL] (6 AMINO 2 BENZOTHIAZOLYLTHIO) ACETAMIDE; N [1 (3,4 DICHLOROBENZYL)PIPERIDIN 4 YL] (6 BENZAMIDO 2 BENZOTHIAZOLYLTHIO)ACETAMIDE; NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG POTENCY; DRUG SYNTHESIS; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

EID: 0348017505     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.51.697     Document Type: Article

References (17)

1. Murphy P. M., Baggiolini M., Charo I. F., Hebert C. A., Horuk R., Matsushima K., Miller L. H., Oppenheim J. J., Power C. A., Pharmacol. Rev., 52, 145-176 (2000).
2. Desreumaux P., Capron M., Curr. Opin. Immunol., 8, 790-795 (1996).
3. Heath H., Qin S. X., Rao P., Wu L. J., Larosa G., Kassam N., Ponath P. D., Mackay C. R., J. Clin. Invest., 99, 178-184 (1997).
4. Jose P. J., Griffiths-Johnson D. A., Collins P. D., Walsh D. T., Moqbel R., Totty N. F., Truong O., Hsuan J. J., Williams T. J., J. Exp. Med., 179, 881-887 (1994).
5. Gonzalo J. A., Jia G. Q., Aguirre V., Friend D., Coyle A. J., Jenkins N. A., Lin G. S., Katz H., Lichtman A., Copeland N., Kopf M., Gutierrezramos J. C., Immunity, 4, 1-14 (1996).
6. Mattoli S., Stacey M. A., Sun G., Bellini A., Marini M., Biochem. Biophys. Res. Commun., 236, 229-301 (1997).
7. Ying S., Robinson D. S., Meng Q., Rottman J., Kennedy R., Ringler D. J., Mackay C. R., Daugherty B. L., Springer M. S., Durham S. R., Williams T. J., Kay A. B., Eur. J. Immunol., 27, 3507-3516 (1997).
8. Lamkhioued B., Renzi P. M., Abi Younes S., Garcia Zepada E. A., Allakhverdi Z., Ghaffar O., Rothenberg M. D., Luster A. D., Hamid Q., J. Immunol., 159, 4593-4601 (1997).
9. Taha R. A., Minshall E. M., Miotto D., Shimbara A., Luster A., Hogg J. C., Hamid Q. A., J. Allergy Clin. Immunol., 103, 476-483 (1999).
10. Gonzalo J. A., Lloyd C. M., Kremer L., Finger E., Martinez A. C., Siegelman M. H., Cybulsky M., Gutierrezramos J. C., J. Clin. Invest., 98, 2332-2345 (1996).
11. Rothenberg M. E., MacLean J. A., Pearlman E., Luster A. D., Leder P., J. Exp. Med., 185, 785-790 (1997).
12. Naya A., Sagara Y., Ohwaki K., Saeki T., Ichikawa D., Iwasawa Y., Noguchi K., Ohtake N., J. Med. Chem., 44, 1429-1435 (2001).
13. Naya A., Kobayashi K., Ishikawa M., Ohwaki K., Saeki T., Noguchi K., Ohtake N., Bioorg. Med. Chem. Lett., 11, 1219-1223 (2001).
14. Carling R. W., Moore K. W., Moyes C. R., Jones E. A., Bonne K., Emms F., Marwood R., Patel S., Fletcher A. E., Beer M., Sohal B., Pike A., Leeson P. D., J. Med. Chem., 42, 2706-2715 (1999).
15. Mach R. H., Leudtke R. R., Unsworth C. D., Boundy V. A., Mowak P. A., Scripko J. G., Elder S. T., Jackson J. R., Hoffman P. L., J. Med. Chem., 36, 3707-3720 (1993).
16. Takahashi T., Okada J., Ueda Y., Yakugaku Zasshi, 78, 437-439 (1958).
17. Woulfe M. R., Miller M. J., J. Org. Chem., 51, 3133-3139 (1986).